Current studentsExisting staffContact us
 

Role of rolapitant in chemotherapy-induced emesis

Simple item page
dc.contributor.authorOlver, I.
dc.date.issued2015
dc.descriptionComment
dc.description.statementofresponsibilityIan Olver
dc.identifier.citationThe Lancet Oncology, 2015; 16(9):1006-1007
dc.identifier.doi10.1016/S1470-2045(15)00096-0
dc.identifier.issn1470-2045
dc.identifier.issn1474-5488
dc.identifier.orcidOlver, I. [0000-0001-5478-1576]
dc.identifier.urihttp://hdl.handle.net/2440/102728
dc.language.isoen
dc.publisherElsevier
dc.rightsCopyright © 2015 Elsevier Ltd. All rights reserved.
dc.source.urihttps://doi.org/10.1016/s1470-2045(15)00096-0
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectNausea
dc.subjectVomiting
dc.subjectSpiro Compounds
dc.subjectFemale
dc.subjectMale
dc.titleRole of rolapitant in chemotherapy-induced emesis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications